Credit Agricole’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $70.3M | Sell |
1,647,566
-374,011
| -19% | -$20.3M | 0.14% | 122 |
|
|
2026
Q1 | $127M | Sell |
2,021,577
-152,420
| -7% | -$12.2M | 0.33% | 49 |
|
|
2025
Q4 | $207M | Buy |
2,173,997
+76,157
| +4% | +$7.47M | 0.47% | 38 |
|
|
2025
Q3 | $205M | Buy |
+2,097,840
| New | +$217M | 0.54% | 30 |
|
|
2025
Q1 | $182M | Sell |
1,805,720
-177,135
| -9% | -$17.8M | 0.57% | 33 |
|
|
2024
Q4 | $177M | Sell |
1,982,855
-153,225
| -7% | -$13.5M | 0.52% | 39 |
|
|
2024
Q3 | $179M | Buy |
2,136,080
+787,126
| +58% | +$62M | 0.77% | 25 |
|
|
2024
Q2 | $104M | Buy |
1,348,954
+1,213,524
| +896% | +$88.8M | 0.56% | 39 |
|
|
2024
Q1 | $9.13M | Buy |
135,430
+48,113
| +55% | +$3.09M | 0.1% | 165 |
|
|
2023
Q4 | $5.05M | Buy |
87,317
+45,456
| +109% | +$2.43M | 0.06% | 210 |
|
|
2023
Q3 | $2.21M | Buy |
41,861
+25,765
| +160% | +$1.35M | 0.04% | 269 |
|
|
2023
Q2 | $871K | Buy |
16,096
+14,619
| +990% | +$764K | 0.02% | 319 |
|
|
2023
Q1 | $73.9K | Buy |
1,477
+156
| +12% | +$7.35K | ﹤0.01% | 467 |
|
|
2022
Q4 | $61.1K | Sell |
1,321
-1,119
| -46% | -$48.5K | ﹤0.01% | 505 |
|
|
2022
Q3 | $95K | Sell |
2,440
-9,926
| -80% | -$398K | ﹤0.01% | 461 |
|
|
2022
Q2 | $461K | Buy |
12,366
+5,933
| +92% | +$242K | 0.01% | 346 |
|
|
2022
Q1 | $285K | Sell |
6,433
-10,078
| -61% | -$437K | 0.01% | 383 |
|
|
2021
Q4 | $701K | Buy |
16,511
+1,256
| +8% | +$52.8K | 0.01% | 320 |
|
|
2021
Q3 | $662K | Buy |
15,255
+13,483
| +761% | +$597K | 0.01% | 300 |
|
|
2021
Q2 | $76K | Buy |
1,772
+772
| +77% | +$32.5K | ﹤0.01% | 449 |
|
|
2021
Q1 | $39K | Buy |
+1,000
| New | +$37.8K | ﹤0.01% | 475 |
|
|
2020
Q4 | – | Sell |
-260
| Closed | -$10K | – | 559 |
|
|
2020
Q3 | $10K | Hold |
260
| – | – | ﹤0.01% | 455 |
|
|
2020
Q2 | $9K | Hold |
260
| – | – | ﹤0.01% | 413 |
|
|
2020
Q1 | $8K | Sell |
260
-39,700
| -99% | -$1.55M | ﹤0.01% | 419 |
|
|
2019
Q4 | $1.81M | Sell |
39,960
-125,500
| -76% | -$5.25M | 0.1% | 137 |
|
|
2019
Q3 | $6.73M | Sell |
165,460
-28,000
| -14% | -$1.19M | 0.33% | 80 |
|
|
2019
Q2 | $8.31M | Hold |
193,460
| – | – | 0.44% | 63 |
|
|
2019
Q1 | $7.43M | Buy |
193,460
+63,460
| +49% | +$2.42M | 0.41% | 58 |
|
|
2018
Q4 | $4.59M | Buy |
130,000
+58,400
| +82% | +$2.12M | 0.26% | 95 |
|
|
2018
Q3 | $2.76M | Buy |
+71,600
| New | +$2.5M | 0.13% | 196 |
|
|
2017
Q4 | – | Sell |
-278,644
| Closed | -$8.13M | – | 466 |
|
|
2017
Q3 | $8.13M | Sell |
278,644
-290,099
| -51% | -$8.01M | 0.03% | 526 |
|
|
2017
Q2 | $15.8M | Buy |
568,743
+79,838
| +16% | +$2.12M | 0.05% | 372 |
|
|
2017
Q1 | $12.2M | Buy |
488,905
+47,795
| +11% | +$1.16M | 0.04% | 490 |
|
|
2016
Q4 | $9.54M | Sell |
441,110
-39
| -0% | -$851 | 0.03% | 509 |
|
|
2016
Q3 | $10.5M | Buy |
441,149
+38,354
| +10% | +$915K | 0.03% | 464 |
|
|
2016
Q2 | $9.41M | Buy |
402,795
+9,257
| +2% | +$200K | 0.04% | 452 |
|
|
2016
Q1 | $7.4M | Buy |
393,538
+80,107
| +26% | +$1.41M | 0.04% | 465 |
|
|
2015
Q4 | $5.78M | Sell |
313,431
-47,894
| -13% | -$858K | 0.03% | 522 |
|
|
2015
Q3 | $5.93M | Buy |
361,325
+52,582
| +17% | +$899K | 0.03% | 520 |
|
|
2015
Q2 | $5.46M | Buy |
308,743
+16,989
| +6% | +$304K | 0.03% | 565 |
|
|
2015
Q1 | $5.18M | Buy |
291,754
+2,753
| +1% | +$43.5K | 0.02% | 608 |
|
|
2014
Q4 | $4.05M | Buy |
289,001
+46,796
| +19% | +$598K | 0.02% | 702 |
|
|
2014
Q3 | $2.86M | Sell |
242,205
-62,654
| -21% | -$789K | 0.01% | 789 |
|
|
2014
Q2 | $3.89M | Sell |
304,859
-114,033
| -27% | -$1.48M | 0.02% | 704 |
|
|
2014
Q1 | $5.66M | Buy |
418,892
+37,414
| +10% | +$491K | 0.02% | 576 |
|
|
2013
Q4 | $4.59M | Sell |
381,478
-51,106
| -12% | -$604K | 0.02% | 634 |
|
|
2013
Q3 | $5.08M | Buy |
+432,584
| New | +$4.68M | 0.02% | 598 |
|
Other funds holding BSX
Credit Agricole's BSX Position: Q2 2026 in Review
Credit Agricole reduced its Boston Scientific (BSX) stake by 19% in Q2 2026, selling an estimated $20.3M and leaving 1,647,566 shares worth $70.3M. The position accounts for 0.14% of the portfolio, ranked #122.
Credit Agricole first reported a position in BSX in Q3 2013 and has held it in 47 quarters since. The position peaked at $207M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Credit Agricole held 1,647,566 shares of Boston Scientific worth $70.3M as of Q2 2026.
- Credit Agricole sold 374,011 Boston Scientific shares in Q2 2026, an estimated $20.3M.
- Boston Scientific made up 0.14% of Credit Agricole's portfolio in Q2 2026, its #122 holding.
- Credit Agricole first reported a position in Boston Scientific in Q3 2013 and has held it in 47 quarters since.
- Credit Agricole's Boston Scientific position peaked at $207M in Q4 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.